Towards in vitro models for reducing or replacing the use of animals in drug testing

David M. Stresser, Anna K. Kopec, Philip Hewitt, Rhiannon N. Hardwick, Terry R. Van Vleet, Prathap Kumar S. Mahalingaiah, Denice O’Connell, Gary J. Jenkins, Rhiannon David, Jessica Graham, Donna Lee, Jason Ekert, Aaron Fullerton, Remi Villenave, Piyush Bajaj, James R. Gosset, Sherry L. Ralston, Manti Guha, Alejandro Amador-Arjona, Kainat Khan, Saket Agarwal, Catrin Hasselgren, Xiaoting Wang, Khary Adams, Gaurav Kaushik, Arkadiusz Raczynski, Kimberly A. Homan
Nature Biomedical Engineering. 2023:1-6. doi: 10.1038/s41551-023-01154-7

Pharmaceutical companies continue to advocate for the use of in vitro models towards the reduction of animal use in drug discovery and development while acknowledging that further advancements are needed to heighten the models’ current state of readiness.

https://www.nature.com/articles/s41551-023-01154-7
Keywords
Assay systems
Drug regulation
Lab-on-a-chip
Scientific community
Tissue engineering
Library Collection(s)
Reviews and perspectives
BibTeX EndNote X3 XML EndNote 7 XML EndNote tagged Marc RIS